NCP-01

N/A

Report date: 2023/02/18 19:35:43

Base Information

Drug NameNCP-01
Drug Alias NameNCP-01
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsSpinal Cord InjuriesAmyotrophic Lateral SclerosisAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHemostemix Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHemostemix Ltd
Inactive CompaniesN/A
Active IndicationsSpinal Cord InjuriesAmyotrophic Lateral SclerosisAlzheimer Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A